1996American Journal of PsychiatryRequires access

Lack of association between polymorphisms in the 5-HT2A receptor gene and the antipsychotic response to clozapine

Anil K. Malhotra, David Goldman, Norio Ozaki, Alan Breier, Robert J. Buchanan, D. Pickar

Open publisher page 127 citations

Abstract

OBJECTIVE: The authors' goal was to determine whether either of two 5-HT2A receptor polymorphisms, 102-T/C and 452-His/Tyr, are associated with clozapine response. METHOD: Brief Psychiatric Rating Scale (BPRS) ratings were obtained in 70 patients with schizophrenia or schizoaffective disorder to determine their response to clozapine compared with a typical neuroleptic. Patients were genotyped with the polymerase chain reaction and restriction fragment length polymorphism analysis. RESULTS: Neither 102-T/C nor 452-His/Tyr was associated with clozapine response. There were no significant differences in BPRS scores among patients with different 5-HT2A genotypes at week 10 of clozapine administration. CONCLUSIONS: Allelic variation in the 5-HT2A gene is not associated with individual differences in clozapine response.

About this research paper

What this paper is about

OBJECTIVE: The authors' goal was to determine whether either of two 5-HT2A receptor polymorphisms, 102-T/C and 452-His/Tyr, are associated with clozapine response. METHOD: Brief Psychiatric Rating Scale (BPRS) ratings were obtained in 70 patients with schizophrenia or schizoaffective disorder to determine their response to clozapine compared with a typical neuroleptic. Patients were genotyped with the polymerase chain reaction and restriction fragment length polymorphism analysis. RESULTS: Neither 102-T/C nor 452-His/Tyr was associated with clozapine response. There were no significant differences in BPRS scores among patients with different 5-HT2A genotypes at week 10 of clozapine administration. CONCLUSIONS: Allelic variation in the 5-HT2A gene is not associated with individual differences in clozapine response.

Why it matters

OpenAlex reports 127 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE: The authors' goal was to determine whether either of two 5-HT2A receptor polymorphisms, 102-T/C and 452-His/Tyr, are associated with clozapine response. METHOD: Brief Psychiatric Rating Scale (BPRS) ratings were obtained in 70 patients with schizophrenia or schizoaffective disorder to determine their response to clozapine compared with a typical neuroleptic. Patients were genotyped with the polymerase chain reaction and restriction fragment length polymorphism analysis. RESULTS: Neither 102-T/C nor 452-His/Tyr was associated with clozapine response. There were no significant differences in BPRS scores among patients with different 5-HT2A genotypes at week 10 of clozapine administration. CONCLUSIONS: Allelic variation in the 5-HT2A gene is not associated with individual differences in clozapine response.

Key concepts: Clozapine, Brief Psychiatric Rating Scale, Schizoaffective disorder, Schizophrenia (object-oriented programming), Antipsychotic, Atypical antipsychotic, Internal medicine, Psychosis

Related papers

Back to paper searchBrowse research topicsOriginal source
Lack of association between polymorphisms in the 5-HT2A receptor gene and the antipsychotic response to clozapine — Research Paper | ScholarLens